Team 57: Clinical Research Groups (GRC) Theranoscan

Sorbonne Université Médecine

Pr Jacques Cadranel

Since 2012, thoracic oncology is the segment of cancerology that has benefited the most from therapeutic innovations based on the best knowledge of cancer biology. These innovations have most often been based on the results of therapeutic trials in humans, which have made it possible to first define subgroups of responder patients, then to understand their molecular mechanisms and then to identify theranostic biomarkers currently used in the clinic. The goal of the Theranoscan GRC project is to participate in the search for biomarkers of sensitivity or resistance either before treatment or occurring under treatment.     Website: Affiliations: UPMC /GRC Theranoscan Contact: